Related Experiment Video
Updated: Aug 1, 2026
07:07
Errors as a Means of Reducing Impulsive Food Choice
Published on: June 5, 2016
Patients' Preferences after Recurrent Coronary Narrowing: Discrete Choice Experiments
Carlos Alberto da Silva Magliano1, Andrea Liborio Monteiro2, Amanda Rebeca de Oliveira Rebelo1
1Instituto Nacional de Cardiologia, Rio de Janeiro, RJ - Brasil.
Arquivos Brasileiros De Cardiologia
|October 28, 2020
Summary
Patients needing repeat coronary revascularization often prefer coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI). This preference highlights the importance of patient choice in treatment decisions for coronary heart disease.
Area of Science:
- Cardiology
- Interventional Cardiology
- Health Services Research
Background:
- Coronary revascularization strategy selection is complex.
- Repeat revascularization is significantly more common after percutaneous coronary intervention (PCI) than coronary artery bypass grafting (CABG).
Purpose of the Study:
- To investigate patient preferences for repeat coronary revascularization strategies.
- To understand patient perspectives on PCI versus CABG after prior interventions.
Main Methods:
- Surveyed patients hospitalized for repeat coronary revascularization.
- Presented hypothetical treatment scenarios comparing PCI and CABG based on risks (perioperative death, long-term death, myocardial infarction, repeat procedure).
- Utilized a conditional logit model to analyze patient choices.
Main Results:
- 144 patients participated; 73.7% preferred CABG over PCI (p < 0.001).
- Key factors influencing choice included PCI label, long-term death risk for both procedures, perioperative death risk for CABG, and repeat CABG likelihood.
- The PCI label was the most significant parameter (p < 0.05).
Conclusions:
- Patients requiring repeat revascularization tend to reject repeat PCI, considering realistic risk-benefit profiles.
- Integrating patient preferences into treatment recommendations can improve patient-centered care for coronary artery disease.
More Related Videos
Related Concept Videos
02:01Group Design
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...